Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II/III data on tafamidis meglumine in TTR-type familial amyloid polyneuropathy

April 20, 2010

Phase III data presented on sodium oxybate in fibromyalgia

April 20, 2010

Updated phase I data presented on JI-101 in solid tumors

April 19, 2010

Studies on progesterone caproate for prevention of preterm birth

April 19, 2010

Mirabegron well tolerated and improves overactive bladder variables in large study

April 19, 2010

Angiochem's EPiC platform yields anticancer drugs with improved brain penetration

April 19, 2010

Merck & Co.'s new GPR119 agonist lowers blood glucose in murine diabetes model

April 19, 2010

AZD-7295 well tolerated in HCV and active against HCV genotype 1b

April 16, 2010

Phase II data on sulopenem-based regimens for community-acquired pneumonia requiring hospitalization

April 16, 2010

Oral CoQ10 improves mitochondrial dysfunction in patients on statin therapy

April 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...